1. Home
  2. ACTU vs VEEA Comparison

ACTU vs VEEA Comparison

Compare ACTU & VEEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • VEEA
  • Stock Information
  • Founded
  • ACTU 2015
  • VEEA 2014
  • Country
  • ACTU United States
  • VEEA United States
  • Employees
  • ACTU N/A
  • VEEA N/A
  • Industry
  • ACTU
  • VEEA
  • Sector
  • ACTU
  • VEEA
  • Exchange
  • ACTU NYSE
  • VEEA NYSE
  • Market Cap
  • ACTU 135.0M
  • VEEA 112.2M
  • IPO Year
  • ACTU 2024
  • VEEA N/A
  • Fundamental
  • Price
  • ACTU $8.00
  • VEEA $1.63
  • Analyst Decision
  • ACTU Strong Buy
  • VEEA
  • Analyst Count
  • ACTU 1
  • VEEA 0
  • Target Price
  • ACTU $20.00
  • VEEA N/A
  • AVG Volume (30 Days)
  • ACTU 42.0K
  • VEEA 13.8K
  • Earning Date
  • ACTU 05-21-2025
  • VEEA 05-23-2025
  • Dividend Yield
  • ACTU N/A
  • VEEA N/A
  • EPS Growth
  • ACTU N/A
  • VEEA N/A
  • EPS
  • ACTU N/A
  • VEEA N/A
  • Revenue
  • ACTU N/A
  • VEEA $141,760.00
  • Revenue This Year
  • ACTU N/A
  • VEEA N/A
  • Revenue Next Year
  • ACTU N/A
  • VEEA N/A
  • P/E Ratio
  • ACTU N/A
  • VEEA N/A
  • Revenue Growth
  • ACTU N/A
  • VEEA N/A
  • 52 Week Low
  • ACTU $5.51
  • VEEA $1.33
  • 52 Week High
  • ACTU $11.73
  • VEEA $18.56
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • VEEA N/A
  • Support Level
  • ACTU N/A
  • VEEA N/A
  • Resistance Level
  • ACTU N/A
  • VEEA N/A
  • Average True Range (ATR)
  • ACTU 0.00
  • VEEA 0.00
  • MACD
  • ACTU 0.00
  • VEEA 0.00
  • Stochastic Oscillator
  • ACTU 0.00
  • VEEA 0.00

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About VEEA VEEA INC

Veea Inc is a company providing edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. It has first-in-class VeeaHub smart computing hubs integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

Share on Social Networks: